Sign In
Buy BMRN
$56.47
+1.81 (+3.31%)
At Close: Jun 04, 2026
Is BioMarin Pharmaceutical (BMRN) Outperforming Other Medical Stocks This Year?
03:30pm, Friday, 07'th Aug 2020
Is (BMRN) Outperforming Other Medical Stocks This Year?
Is BioMarin Pharmaceutical (BMRN) Outperforming Other Medical Stocks This Year?
11:30am, Friday, 07'th Aug 2020
Is (BMRN) Outperforming Other Medical Stocks This Year?
BioMarin (BMRN) Q2 Earnings Top, Sales Show Coronavirus Impact
03:57pm, Wednesday, 05'th Aug 2020
BioMarin (BMRN) reports better-than-expected second-quarter results. The company maintains its previously issued guidance for 2020.
BioMarin (BMRN) Q2 Earnings Top, Sales Show Coronavirus Impact
11:57am, Wednesday, 05'th Aug 2020
BioMarin (BMRN) reports better-than-expected second-quarter results. The company maintains its previously issued guidance for 2020.
How Biomarin Beat Expectations in Q2
10:35am, Wednesday, 05'th Aug 2020
You won't find many people who would complain about BioMarin Pharmaceutical's (NASDAQ: BMRN) performance so far this year. Here are the highlights from BioMarin's Q2 update. The company announced a
How Biomarin Beat Expectations in Q2
06:35am, Wednesday, 05'th Aug 2020
Two of the biotech's drugs performed especially well in the second quarter.
Biomarin Pharmaceutical Inc (BMRN) Q2 2020 Earnings Call Transcript
06:01am, Wednesday, 05'th Aug 2020
Hosting the conference call today from BioMarin is Traci McCarty, Vice President of Investor Relations. To remind you, this non-confidential presentation contains forward-looking statements about the
BioMarin Pharmaceutical (BMRN) Q2 Earnings and Revenues Beat Estimates
09:35pm, Tuesday, 04'th Aug 2020
BioMarin (BMRN) delivered earnings and revenue surprises of 100.00% and 2.74%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Lion Biotechnologies Reaches 80-Plus Relative Strength Rating Benchmark
09:33pm, Tuesday, 04'th Aug 2020
One important metric to look for in a stock is an 80 or higher Relative Strength Rating. When you're researching the best stocks to buy and watch, be sure to pay attention to relative price strength.
BioMarin Pharmaceutical Inc.'s (BMRN) CEO Jean-Jacques Bienaimé on Q2 2020 Results - Earnings Call Transcript
09:15pm, Tuesday, 04'th Aug 2020
BioMarin Pharmaceutical Inc.'s (BMRN) CEO Jean-Jacques Bienaimé on Q2 2020 Results - Earnings Call Transcript
BioMarin Announces Second Quarter 2020 Total Revenue Growth of 11% to $430 million
08:05pm, Tuesday, 04'th Aug 2020
Financial Highlights (in millions of U.S. dollars, except per share data, unaudited)
BioMarin Pharmaceutical (BMRN) Q2 Earnings and Revenues Beat Estimates
05:35pm, Tuesday, 04'th Aug 2020
BioMarin (BMRN) delivered earnings and revenue surprises of 100.00% and 2.74%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
BioMarin Announces Second Quarter 2020 Total Revenue Growth of 11% to $430 million
04:05pm, Tuesday, 04'th Aug 2020
SAN RAFAEL, Calif., Aug. 4, 2020 /PRNewswire/ -- Financial Highlights (in millions of U.S.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 3)
ABIOMED, Inc. (NASDAQ: ABMD)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Annexon Inc (NASDAQ: ANNX)
Atossa...
Composite Rating For Emergent Biosolutions Rises To 99
10:27pm, Monday, 03'rd Aug 2020
Emergent Biosolutions saw its IBD SmartSelect Composite Rating jump to 99 Monday, up from 94 the day before. The upgrade means the stock currently tops 99% of all other stocks in terms of key performa
